Welcome to the Peers in Practice inhale hub. Here you will find information to support your COPD consultations with your patients
Adverse events reporting and prescribing information can be found at the bottom of the page.
This material was developed in collaboration with a UCL Business company, Personia Health, industry leaders in the application of validated behavioural science frameworks and tools developed from extensive research into helping patients and healthcare professionals to get the best from treatments by enhancing engagement, adherence and persistence to optimise health.1
Healthcare professionals have been consulted by GSK and received honorarium.
Resources to Support Change
Support better COPD care with practical tools for healthcare professionals.
Explore resources designed to enhance patient support and build effective inhaler habits.
Read on to find out more
Supporting patients beyond the consultation
Consultations are just one part of a patient’s change journey. Ongoing support can help patients build confidence, establish new routines, and make treatment feel more manageable at home.2
The Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) COPD Patient Support Packs provide practical materials that clinicians can use to reinforce discussions from the consultation and support day-to-day COPD management after a decision to prescribe Trelegy Ellipta has been made.
| Action Planner | Your Trelegy Ellipta® | COPD Consultation Support |
|---|---|---|
| To help patients with COPD set realistic and achievable goals for lasting behaviour change | Getting comfortable with your Ellipta device with step-by-step instructions | Let’s help maximise the time you spend together during appointments |
Potential increased patient ownership of their COPD management, through comprehensive post-consultation support that breaks down their behaviour change journeys into more manageable and achievable steps
Efficient use of consultation time, with educated and collaborative patients committed to owning their COPD care
Follow-up queries - the Trelegy Ellipta COPD Patient Support Packs could pre-emptively address common questions and concerns from your patients, reallocating your time and increasing your capacity
“The Trelegy Ellipta COPD Patient Support Packs give patients a chance to reflect on consultations, think through what we’ve discussed, and return with further questions. I’d encourage healthcare professionals to use them — they help patients understand how best to manage their condition.”
Who is Dr Beverley Bostock?
Adverse events reporting and prescribing information can be found at the bottom of the page.
Why use the Trelegy Ellipta COPD Patient Support Pack?
*Please note that the Support Packs are only available for patients once a Trelegy Ellipta® prescribing decision has been made.
Trelegy Ellipta COPD Patient Support Packs
From inhaler technique support to daily tips, the Trelegy Ellipta COPD Patient Support Packs help patients prescribed Trelegy Ellipta® adapt to a new device and manage their COPD with confidence.
Help your patients in their change journey.
Now digital
COPD Action Planner and Symptom Tracker
These one-page digital tools are designed for regular use, helping patients build effective inhaler habits and track symptoms to support proactive, long-term COPD management.
GOLD and NICE Recommendations
for your use as a healthcare professional
GSK have reviewed where GOLD and NICE align on recommendations for COPD treatment. These are displayed in the adapted infographic, in the context of UK licencing indications. As healthcare professionals, staying informed and updated with the latest COPD information is an excellent way to continue providing quality care for your patients.
Copyright
GSK-adapted from ©2026 Global Strategy for the Diagnosis, Management and Prevention of COPD. All rights reserved. Use is by express license from the owner.
GSK-adapted from ©NICE 2019. COPD in over 16s: diagnosis and management. Available from www.nice.org.uk/guidance/ng115. All rights reserved. Subject Notice of rights. NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this material.
ANORO Ellipta (umeclidinium/vilanterol) was developed in collaboration with INNOVIVA Inc.
For the ANORO Ellipta (umeclidinium/vilanterol) prescribing information Click here.
Our dedicated team is here to support you
Connect with a GSK Team Member
Stay up-to-date with the latest information
Sign up NowAbbreviations
ARNS, Association of Respiratory Nurse Specialists; COPD, chronic obstructive pulmonary disease; GOLD, Global Initiative for Chronic Obstructive Lung Disease; NICE, National Institute for Health and Care Excellence.
References
- Personia Health, a University College London Business company - making the most of medicines and vaccines. Available at: https://personiahealth.com
- GOLD. Global strategy for the Diagnosis, Management and Prevention of COPD. 2026 Report. Available at: https://goldcopd.org/2026-gold-report-and-pocket-guide/
March 2026 | PM-GB-CPU-WCNT-240007 (V2.0)
For the Trelegy Ellipta® (fluticasone furoate/umeclidinium/vilanterol) prescribing information Click here.
Beverley is an Advanced Nurse Practitioner in Gloucestershire and an independent prescriber. She is the Asthma Lead for ARNS, Chair of the ARNS Respiratory Diseases committee, and sits on the Executive Committee of the PCRS and Asthma and Lung UK's Council of Healthcare Professionals. She holds an MSc in Respiratory Care and an MA in Medical Ethics and Law. Bev was part of the NICE Asthma Quality Standards development and the National Review of Asthma Deaths. She is Editor in Chief of Practice Nurse Journal and has been a Queen’s Nurse since 2015.
